Skip to search formSkip to main contentSkip to account menu

Cytokeratin Fragment 21-1 Measurement

Known as: Cytokeratin 19 Fragment, CYFRA211, Cytokeratin Fragment 21-1 
The determination of the amount of the cytokeratin 19 fragment 21-1 present in a sample.
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Fine-Needle Aspirates CYFRA 21-1 is a Useful Tumor Marker for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients
Introduction To assess whether the value of CYFRA21-1 in the aspirates of ultrasonography-guided fine-needle aspiration biopsy… 
2013
2013
Clinical significance of serum transforming growth factor-β1 in lung cancer.
2013
2013
Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markers
Tumor markers are commonly used to detect a relapse of disease in oncologic patients during follow-up. It is important to… 
2010
2010
Predictors of sensitivity to chemoradiotherapy of esophageal squamous cell carcinoma
The purpose of this study was to investigate clinical–biological factors which could predict the sensitivity to chemoradiotherapy… 
2009
2009
The follow-up of patients with non-muscle-invasive bladder cancer by urine cytology, abdominal ultrasound and urine CYFRA 21-1: a pilot study.
AIM This study aimed to evaluate the accuracy of urine cytology, bladder ultrasound (US), urine cytokeratin 19 fragment assay… 
2007
2007
Clinical value of CYFRA21‐1, NSE, CA15‐3, CA19‐9 and CA125 assay in the elderly patients with pleural effusions
The aim of this study was to evaluate the individual and combined diagnostic value of five tumour markers in the elderly patients… 
Highly Cited
2003
Highly Cited
2003
Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
BACKGROUND We previously reported that positron emission tomography (PET) with 18-F-fluorodeoxyglucose (FDG) might be a useful… 
2003
2003
Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancer.
Midkine, a heparin-binding growth factor, is expressed in numerous cancer tissues and is reportedly elevated in patients with… 
1999
1999
Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion.
BACKGROUND The aim was to investigate the diagnostic utility of CYFRA 21-1 (cytokeratin 19 fragment) as a tumor marker in pleural… 
1997
1997
Production of cytokeratin 19 fragment by human squamous lung cancer cell lines.
Cytokeratins form part of the cytoskeleton of both normal and malignant epithelium. A novel tumor marker measuring cytokeratin 19… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)